Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGT1 | P19440 | 1/20 | 0.52 |
| ▸ | ARG1 | P05089 | 1/20 | 0.47 |
| ▸ | ARG2 | P78540 | 1/20 | 0.47 |
| ▸ | NOS2 | P35228 | 5/20 | 0.41 |
| ▸ | NOS1 | P29475 | 3/20 | 0.41 |
| ▸ | NOS3 | P29474 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 2/20 | 0.37 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | FYN | P06241 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL162368 | 1.00 | GGT1 (0.52) | GGT1ARG1ARG2NOS2NOS1 | |
| SCHEMBL5614525 | 1.00 | GGT1 (0.52) | GGT1ARG1ARG2NOS2NOS1 | |
| SCHEMBL162014 | 1.00 | GGT1 (0.52) | GGT1ARG1ARG2NOS2NOS1 | |
| SCHEMBL5614536 | 1.00 | GGT1 (0.52) | GGT1ARG1ARG2NOS2NOS1 | |
| Hydrochloric Acid SCHEMBL13585526 | 0.98 | GGT1 (0.50) | GGT1ARG1ARG2NOS2NOS1 | |
| SCHEMBL4263059 | 0.90 | GGT1 (0.44) | GGT1ARG1ARG2NOS2NOS1 | |
| SCHEMBL29054949 | 0.89 | GGT1 (0.43) | GGT1ARG1ARG2NOS2NOS1 | |
| SCHEMBL2720103 | 0.89 | ARG1 (0.47) | GGT1ARG1ARG2NOS2NOS1 | |
| SCHEMBL11192504 | 0.82 | NOS1 (0.33) | GGT1ARG1ARG2NOS2NOS1 | |
| SCHEMBL8687592 | 0.80 | GGT1 (0.65) | GGT1ARG1ARG2NOS2NOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 781 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110914425-B | High Throughput (HTP) genome engineering platform for improving spinosyns | 齐默尔根公司 | 2024-06-25 | — | — | CN | claimed |
| CN-116670151-A | Antibacterial cyclic peptides targeting acinetobacter and other gram negative pathogens | 犹他大学研究基金会 | 2023-08-29 | — | — | CN | claimed |
| US-20230111252-A1 | THIOSEMICARBAZATES AND USES THEREOF | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2023-04-13 | — | — | US | claimed |
| US-20200115705-A1 | A HIGH-THROUGHPUT (HTP) GENOMIC ENGINEERING PLATFORM FOR IMPROVING SACCHAROPOLYSPORA SPINOSA | ZYMERGEN INC. (US) | 2020-04-16 | — | — | US | claimed |
| EP-3635110-A2 | A HIGH-THROUGHPUT (HTP) GENOMIC ENGINEERING PLATFORM FOR IMPROVING SACCHAROPOLYSPORA SPINOSA | Zymergen, Inc. (US) | 2020-04-15 | — | — | EP | claimed |
| CN-110914425-A | High Throughput (HTP) genome engineering platform for improving saccharopolyspora spinosa | 齐默尔根公司 | 2020-03-24 | — | — | CN | claimed |
| CN-109477840-A | For non-destructively determining the method and system of Fowl Sex in ovum | 因欧沃私人有限责任公司 | 2019-03-15 | — | — | CN | claimed |
| WO-2018226893-A2 | A HIGH-THROUGHPUT (HTP) GENOMIC ENGINEERING PLATFORM FOR IMPROVING SACCHAROPOLYSPORA SPINOSA | ZYMERGEN INC. (US) | 2018-12-13 | — | — | WO | claimed |
| EP-1591520-B1 | Microorganism producing L-threonine having inactivated tyR gene, method of producing the same and method of producing L-threonine using the microorganism | CJ CHEILJEDANG CORP (KR) | 2017-11-29 | — | — | EP | claimed |
| US-20160318987-A1 | PROTEASE RESISTANT PEPTIDES | MEDIMMUNE LIMITED (GB) | 2016-11-03 | — | — | US | claimed |
| WO-2004045539-A2 | ANTI-MICROBIAL AGENTS DERIVED FROM METHIONINE SULFOXIMINE ANALOGUES | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2004-06-03 | — | — | WO | claimed |
| EP-1017358-A1 | REDUCTION OF HAIR GROWTH | THE GILLETTE COMPANY (US) | 2000-07-12 | — | — | EP | claimed |
| US-5939458-A | APPLYING AN INHIBITOR OF AMINOACYL-TRNA SYNTHETASE TO THE SKIN | GILLETTE COMPANY, THE | 1999-08-17 | — | — | US | claimed |
| US-5925551-A | MUTANT ASPERGILLUS TERREUS STRAIN; FOR HIGH PRODUCTION OF MEVINOLINIC ACID, A CHEMICAL INTERMEDIATE OF LOVASTATIN; BY-PRODUCT INHIBITION; USING MONOSACCHARIDES LIKE GLUCOSE AND GALACTOSE AS CARBON SOURCE DURING FERMENTATION | CHONG KUN DANG CORPORATION (KR) | 1999-07-20 | — | — | US | claimed |
| WO-1999015136-A1 | REDUCTION OF HAIR GROWTH | THE GILLETTE COMPANY (US) | 1999-04-01 | — | — | WO | claimed |
| CN-1036832-C | Composition containing a penem or carbapenem artibiotic and the use of the same | SANKYO CO (JP) | 1997-12-31 | — | — | CN | claimed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | claimed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
| CN-86107574-A | Compositions containing penem or carbapenem antibiotics and their use | — | 1987-05-20 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230111252-A1 | THIOSEMICARBAZATES AND USES THEREOF | TST, ABAT, AADAC | GGT1 628/4885ARG1 2587/4885ARG2 1813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.